Biodesix (BDSX) Short-term Investments (2021 - 2022)

Biodesix's (BDSX) quarterly Short-term Investments came in at $100000.0 in Q2 2022, little changed on a QoQ basis from $100000.0 in Q4 2021.

Biodesix (BDSX) Short-term Investments (2021 - 2022) Analysis & Trends

Biodesix (BDSX) has 2 years of Short-term Investments data on file, last reported at $100000.0 in Q2 2022.

Quarterly Short-term Investments changed N/A year-over-year to $100000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $100000.0 (changed N/A YoY) and the FY2021 annual result came in at $100000.0, changed N/A from the prior year.
Short-term Investments held at $100000.0 in Q2 2022, from $100000.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $100000.0 in Q4 2021 to a low of $100000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	Biodesix	220.74 Mn	195.16 Mn	21.35 Mn

Download Data

Date	Value
Jun 30, 2022	100,000.00
Dec 31, 2021	100,000.00